Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 412.57 | 322.01 | 237.52 | 312.72 |
Depreciation/ Depletion | 53.59 | 54.03 | 50.05 | 27.52 |
Non- Cash Items | -16.16 | -5.19 | 2.75 | -9.49 |
Changesin Working Capital | -184.53 | -124.86 | -82.84 | -163.94 |
Cashfrom Operating Activities | 265.47 | 246.00 | 207.48 | 166.82 |
Capital Expenditures | -85.69 | -145.08 | -155.51 | -204.18 |
Other Investing Cash Flow Items Total | -68.92 | -12.87 | 43.72 | 8.97 |
Cashfrom Investing Activities | -154.61 | -157.95 | -111.79 | -195.21 |
Financing Cash Flow Items | -1.26 | -4.88 | -72.75 | -5.71 |
Total Cash Dividends Paid | -71.45 | -53.56 | - | - |
Issuance( Retirement)of Debt Net | -26.50 | -26.78 | -27.42 | 36.83 |
Cashfrom Financing Activities | -99.21 | -85.22 | -100.16 | 31.12 |
Net Changein Cash | 11.64 | 2.83 | -4.48 | 2.74 |
Cash Interest Paid | 2.65 | 3.78 | 5.32 | 0.00 |
Cash Taxes Paid | 103.35 | 70.28 | 60.79 | 75.18 |
Concord Biotech Dividend Concord Biotech Bonus Concord Biotech News Concord Biotech AGM Concord Biotech Rights Concord Biotech Splits Concord Biotech Board Meetings Concord Biotech Key Metrics Concord Biotech Shareholdings Concord Biotech Profit Loss Concord Biotech Balance Sheet Concord Biotech Q1 Results Concord Biotech Q2 Results Concord Biotech Q3 Results Concord Biotech Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks